10,000+ stock pitches from top investors available on joinyellowbrick.com
Redmile Group, LLC 13F Holdings
Holdings from the most recent 13F from Redmile Group, LLC
Filed: 2020-11-16 (Q3 2020) | Holdings: 81 | Value: $5.4B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
---|---|---|---|---|---|---|---|
Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
FATE - FATE THERAPEUTICS INC | 9.27% | $504.8M | -97.68% | +97.89% | +2.53% | ||
FOLD - AMICUS THERAPEUTICS INC | Reduce 7% $(26.4M) | 5.98% | $325.8M | -74.45% | -45.88% | -48.33% | |
IMMU - IMMUNOMEDICS INC | Reduce 7% $(21.7M) | 5.05% | $275.1M | ||||
ARGX - ARGENX SE | Reduce 4% $(12.2M) | 4.76% | $259.5M | +107.08% | +42.68% | +15.64% | |
IGMS - IGM BIOSCIENCES INC | Add 9% ($20.8M) | 4.64% | $252.8M | -97.85% | +79.36% | +12.84% | |
DCPH - DECIPHERA PHARMACEUTICALS IN | Reduce 4% $(10.5M) | 4.50% | $245.0M | -29.69% | -86.53% | ||
ADCT - ADC THERAPEUTICS SA | Add 15% ($27.3M) | 3.85% | $209.6M | -91.05% | -6.76% | -26.17% | |
ALLK - ALLAKOS INC | Reduce 7% $(15.8M) | 3.63% | $197.6M | +36.87% | -17.04% | ||
GILD - GILEAD SCIENCES INC | New Purchase | 3.33% | $181.4M | +114.74% | +8.28% | +15.83% | |
OSH - OAK STR HEALTH INC | New Purchase | 2.60% | $141.7M | +34.47% | -13.12% | ||
ANNX - ANNEXON INC | New Purchase | 1.91% | $104.1M | -89.81% | +26.96% | -37.15% | |
EPZM - EPIZYME INC | Reduce 2% $(2.1M) | 1.82% | $99.2M | -6.36% | -65.25% | ||
ONEM - 1LIFE HEALTHCARE INC | Add 11% ($9.5M) | 1.74% | $94.9M | +67.47% | -33.74% | ||
BIIB - BIOGEN INC | Add 102% ($46.8M) | 1.71% | $92.9M | -49.62% | +10.15% | +2.87% | |
NRIX - NURIX THERAPEUTICS INC | New Purchase | 1.66% | $90.5M | -63.86% | +23.70% | +5.23% | |
ATRA - ATARA BIOTHERAPEUTICS INC | Add 1% ($1.2M) | 1.65% | $89.9M | -98.34% | -5.13% | -7.77% | |
KYMR - KYMERA THERAPEUTICS INC | New Purchase | 1.62% | $88.3M | -0.32% | +27.09% | +34.34% | |
SAN - SANOFI | Add 42% ($26.0M) | 1.61% | $87.4M | +8.55% | -5.76% | +3.68% | |
BNTX - BIONTECH SE | Reduce 60% $(126.9M) | 1.57% | $85.5M | +18.44% | +27.60% | +205.62% | |
STOK - STOKE THERAPEUTICS INC | Add 2% ($1.6M) | 1.57% | $85.4M | -74.29% | +35.07% | -37.33% | |
BEAM - BEAM THERAPEUTICS INC | Reduce 1% $(731.1K) | 1.50% | $81.9M | -54.83% | +183.04% | +136.43% | |
ZNTL - ZENTALIS PHARMACEUTICALS INC | Add 46% ($25.2M) | 1.46% | $79.5M | -96.56% | -6.96% | +97.71% | |
PLRX - PLIANT THERAPEUTICS INC | Reduce 1% $(428.1K) | 1.41% | $76.8M | -94.95% | +23.15% | -37.21% | |
REPL - REPLIMUNE GROUP INC | Add 7% ($5.2M) | 1.41% | $76.7M | -79.53% | -21.27% | -28.22% | |
RPTX - REPARE THERAPEUTICS INC | Add 1% ($578.5K) | 1.36% | $74.0M | -94.87% | +19.82% | -1.56% | |
AKRO - AKERO THERAPEUTICS INC | New Purchase | 1.32% | $71.9M | +98.63% | +17.26% | -7.85% | |
CI - CIGNA CORP NEW | Reduce 18% $(15.1M) | 1.23% | $67.2M | +57.54% | -3.62% | +1.83% | |
GNMK - GENMARK DIAGNOSTICS INC | Reduce 4% $(2.7M) | 1.23% | $66.9M | +61.06% | |||
KRYS - KRYSTAL BIOTECH INC | Add 7% ($4.0M) | 1.19% | $64.7M | +216.38% | +80.34% | +17.58% | |
ALVR - ALLOVIR INC | New Purchase | 1.18% | $64.2M | +34.76% | -31.23% | ||
NVRO - NEVRO CORP | Reduce 8% $(5.3M) | 1.18% | $64.0M | +5.02% | -45.39% | ||
RGNX - REGENXBIO INC | 1.13% | $61.3M | -75.85% | +26.04% | -11.25% | ||
TCRR - TCR2 THERAPEUTICS INC | New Purchase | 1.04% | $56.8M | +8.63% | -75.55% | ||
APRE - APREA THERAPEUTICS INC | 1.00% | $54.6M | |||||
BSX - BOSTON SCIENTIFIC CORP | Add 58% ($20.0M) | 1.00% | $54.3M | +185.63% | +5.66% | +17.24% | |
SRRK - SCHOLAR ROCK HLDG CORP | Add 1% ($442.3K) | 0.94% | $51.3M | -5.12% | +35.37% | -10.29% | |
ZYME - ZYMEWORKS INC | Add 41% ($14.8M) | 0.94% | $51.3M | -69.83% | -2.08% | -53.23% | |
NLTX - NEOLEUKIN THERAPEUTICS INC | Add 3% ($1.6M) | 0.92% | $50.1M | ||||
RCEL - AVITA THERAPEUTICS INC | New Purchase | 0.82% | $44.8M | -76.35% | +14.19% | -28.96% | |
QURE - UNIQURE NV | Reduce 9% $(4.4M) | 0.76% | $41.6M | -65.68% | -20.45% | -31.98% | |
AXNX - AXONICS MODULATION TECHNOLOG | Reduce 38% $(23.0M) | 0.69% | $37.8M | +20.53% | +37.98% | ||
IMGN - IMMUNOGEN INC | Reduce 13% $(5.5M) | 0.69% | $37.7M | +57.07% | -5.06% | ||
BCEL - ATRECA INC | New Purchase | 0.65% | $35.6M | +23.96% | -65.35% | ||
DXCM - DEXCOM INC | Reduce 14% $(5.7M) | 0.63% | $34.4M | -3.80% | +22.94% | +93.34% | |
AMED - AMEDISYS INC | Reduce 38% $(20.3M) | 0.61% | $33.1M | -59.76% | +21.35% | -26.89% | |
PPD - PPD INC | Reduce 56% $(40.0M) | 0.58% | $31.6M | +4.86% | +34.73% | ||
CLDX - CELLDEX THERAPEUTICS INC NEW | New Purchase | 0.54% | $29.5M | +8.38% | +33.26% | +128.11% | |
ICUI - ICU MED INC | Reduce 22% $(7.9M) | 0.53% | $28.9M | -31.08% | +17.46% | +32.53% | |
CTLT - CATALENT INC | Reduce 20% $(7.2M) | 0.52% | $28.2M | +15.32% | +24.00% | ||
PRAH - PRA HEALTH SCIENCES INC | New Purchase | 0.52% | $28.2M | +13.28% | |||
CYRX - CRYOPORT INC | Reduce 100% | 0.00% | $0.00 | -85.88% | +33.30% | +46.08% | |
DVAX - DYNAVAX TECHNOLOGIES CORP | Reduce 100% | 0.00% | $0.00 | ||||
EIDX - EIDOS THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
GMAB - GENMAB A/S | Reduce 100% | 0.00% | $0.00 | -39.35% | +15.29% | +20.14% | |
HRC - HILL ROM HLDGS INC | Reduce 100% | 0.00% | $0.00 | ||||
LMNX - LUMINEX CORP DEL | Reduce 100% | 0.00% | $0.00 | ||||
MRK - MERCK & CO. INC | Reduce 100% | 0.00% | $0.00 | +48.52% | -6.07% | +10.57% | |
MNTA - MOMENTA PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
NVS - NOVARTIS AG | Reduce 100% | 0.00% | $0.00 | +42.34% | +3.61% | -3.52% | |
PRNB - PRINCIPIA BIOPHARMA INC | Reduce 100% | 0.00% | $0.00 | ||||
TCDA - TRICIDA INC | Reduce 100% | 0.00% | $0.00 | ||||
UNH - UNITEDHEALTH GROUP INC | Reduce 100% | 0.00% | $0.00 | +83.30% | -6.91% | +29.24% |